SMOC2, an intestinal stem cell marker, is an independent prognostic marker associated with better survival in colorectal cancers
Bo Gun Jang(Jeju National University), Gyeong Hoon Kang(Seoul National University)
Cited by 57
Related Papers
Epstein-Barr Virus-Positive Gastric Carcinoma Demonstrates Frequent Aberrant Methylation of Multiple Genes and Constitutes CpG Island Methylator Phenotype-Positive Gastric Carcinoma
|American Journal Of Pathology|2002|330
Characterisation of PD-L1-positive subsets of microsatellite-unstable colorectal cancers
|British Journal of Cancer|2016|123
Expression Profile of LGR5 and Its Prognostic Significance in Colorectal Cancer Progression
|American Journal Of Pathology|2018|57
Expression status of wild-type HSP110 correlates with HSP110 T17 deletion size and patient prognosis in microsatellite-unstable colorectal cancer
|Modern Pathology|2013|31
Pathologic Factors Associated with Prognosis after Adjuvant Chemotherapy in Stage II/III Microsatellite-Unstable Colorectal Cancers
|Journal of Pathology and Translational Medicine|2015|20